Skip to main content

Table 3 Logistic regression model for prediction of pathologic complete response (pCR) in the EORTC cohort (n = 99)

From: Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer

 

OR (95% CI)

Pvalue

Size T3 vs T1/T2

0.38 (0.15-0.95)

0.037

Grade 3 vs 1/2

1.77 (0.76-4.11)

0.186

Node 1 vs 0a

0.62 (0.25-1.51)

0.620

Age ≥50 vs <50

0.69 (0.27-1.75)

0.433

Her2 A vs Nb

1.97 (0.66-5.92)

0.227

FEC vs TET

0.64 (0.26-1.59)

0.337

TIL high vs low

6.42 (2.08-19.83)

0.001

  1. a1, lymph node positive; 0, lymph node negative; bA, amplified; N, not amplified.